Former Pfizer Scientist Is Resurrecting Projects To Solve The Multidrug Resistant Bacteria Problem
Despite this success, Dr. Dunne wasn ’t done with Pfizer and his former anti-infective portfolio.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: NYSE:PFE NYSE:AGN Source Type: news